Author:
Saremi Marzieh,Saremi Leila,Feizy Fatemeh,Vafaei Somayeh,Lashkari Ali,Saltanatpour Zohreh,Nazari Razieh Nazari, , , , , , ,
Reference47 articles.
1. 1. Tumbarello, M., et al., Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clinical infectious diseases, 2012. 55(7): p. 943-950.
2. 2. KONG, K.F., L. Schneper, and K. Mathee, Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology. Apmis, 2010. 118(1): p. 1-36.
3. 3. Rahbar, M., et al., Carbapenem resistance in gram-negative bacilli isolates in an Iranian 1000-bed Tertiary Hospital. Pak J Med Sci, 2008. 24(4): p. 537-40.
4. 4. Johnson, J.R. and T.A. Russo, Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. International journal of medical microbiology, 2005. 295(6-7): p. 383-404.
5. 5. Bush, K. and G.A. Jacoby, Updated functional classification of β-lactamases. Antimicrobial agents and chemotherapy, 2010. 54(3): p. 969-976.